CHMP recommends approval of Ontozry for focal – onset (partial-onset) seizures – SK Biopharmaceuticals
SK Biopharmaceuticals announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use.
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.